Campaign - Sansum Diabetes Research Institute

Central Nursing Station

Overnight Research Room

Clinical Research Space

Patient Waiting Room

2nd Floor Reception

Patient Exam Room

Exterior of Building

SDRI’s future research will explore an exciting new frontier: beyond insulin. Aimed at reducing insulin dependence, SDRI is uniquely positioned to become a world leader in the new science of Precision Metabolism related to all types of diabetes.

The Challenge

Diabetes is a major public health problem in the U.S., particularly in under-served populations. People with diabetes are at high risk for serious medical complications including coronary heart disease, blindness, chronic kidney disease, chronic liver disease, and vascular disease requiring limb amputation.

SDRI is embarking on an aggressive program of sophisticated clinical research that requires an appropriate and modern research unit. However, SDRI’s clinical research facilities have not been modified since 1975. Updating our research facilities is critical for conducting leading edge clinical research and is necessary to recruit top-tier clinical investigators. We have developed the architectural plans to establish a state-of the-art clinical research unit and look forward to being able to proceed with construction.

Dr. Samuel Klein
Chief Scientific Officer

SDRI is embarking on an aggressive program of sophisticated clinical research that requires an appropriate and modern research unit. However, SDRI’s clinical research facilities have not been modified since 1975. Updating our research facilities is critical for conducting leading edge clinical research and is necessary to recruit top-tier clinical investigators. We have developed the architectural plans to establish a state-of the-art clinical research unit and look forward to being able to proceed with construction.

Dr. Samuel Klein
Chief Scientific Officer

Learn More

The Future

SDRI’s future research will explore an exciting new frontier: beyond insulin. Aimed at reducing insulin dependence, SDRI is uniquely positioned to become a world leader in the new science of Precision Metabolism related to all types of diabetes.

Samuel Klein, MD, SDRI’s Chief Scientific Officer, leads us in this endeavor. Dr. Klein is internationally respected for his clinical research in metabolic diseases. Dr. Klein has consistently received research funding from the National Institutes of Health for 30 years, published over 475 peer-reviewed papers, and received many national and international awards recognizing his research.

“SDRI is a unique research organization that is nimble and creative and can move quickly to become a leader in the field of metabolic research, part of the cutting-edge research in Precision Metabolism,” says Dr. Klein. “This area of research aims to create new therapeutic strategies for people with diabetes and those at risk for developing diabetes and metabolic diseases.”

While major academic centers conduct research in cell cultures or mice, precision metabolic research requires sophisticated, leading-edge studies in people—something SDRI is uniquely equipped to do and academic centers are not. In order to successfully conduct this sophisticated clinical research, we need to invest in our infrastructure and research team. These investments are aimed at developing a programmatic critical mass to conduct the highest quality research leading to a self sustaining organization.

SDRI Needs Your Partnership

Leading-edge clinical research is expensive. Accomplishing our ambitious vision will require a significant investment that is only possible through a generous infusion of philanthropic support to:

Expand our research capacity and technical expertise by recruiting the next generation of outstanding physician-scientists to conduct sophisticated clinical studies
Provide seed funding for new research initiatives
Construct a state-of-the-art clinical research unit within our current building